Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
CVS HEALTH Corp
Bear Case (25th pct.)
-51.2% vs price
Base Case (Median)
-25.2% vs price
Bull Case (75th pct.)
-11.7% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| PE Comparable | $83.53 | -11.7% | Medium (25%) |
| Graham Number | $70.72 | -25.2% | Medium (40%) |
| EV/EBITDA | $20.47 | -78.3% | Medium (20%) |
| EV/FCF | $126.92 | 34.2% | Medium (20%) |
| Earnings Power Value | $46.15 | -51.2% | Medium (50%) |
Based on 5 out of 7 methods, CVS appears overvalued at the current price of $94.55. The base case fair value of $70.72 implies 25.2% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.